PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826FAF3L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $30,324
Award facts
- Contract value 100% obligated
- $30,324.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 12, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $30,324 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc. This competitively awarded, firm fixed-price delivery order is scheduled for completion by January 13, 2026, with performance at the awardee's Conshohocken, Pennsylvania location. The award was not designated as a set-aside contract. This delivery order is issued under AmerSourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999 and extends through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerSourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's contract portfolio demonstrates extensive capability in delivering prescription medications, brand-name and generic drugs, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The parent organization, Cencora, Inc., also holds a significant IDC with the Defense Logistics Agency valued at up to $999,999,999 through December 31, 2031, further demonstrating the companies' substantial role in supplying essential pharmaceutical and medical commodities to military treatment facilities and federal medical institutions.
Quick answers
Who was awarded contract SPE2D826FAF3L?
SPE2D826FAF3L was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on January 12, 2026.
How much is contract SPE2D826FAF3L worth?
The government has obligated $30,324 on SPE2D826FAF3L.
Is contract SPE2D826FAF3L an order under another contract?
Yes. SPE2D826FAF3L is a delivery order under SPE2DX22D0099, an indefinite delivery contract.
Was contract SPE2D826FAF3L competed?
The extent of competition for SPE2D826FAF3L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award